Filters

Clear all

Expert Opinion

Plain Language Summary

Expert Review

Text Availability

Abstract

112

Full text

Free full text

Publication Types

Journal Article

112

Research Support, Non-U.S. Gov't

Clinical Trial, Phase II

Randomized Controlled Trial

Multicenter Study

Review

Clinical Trial

Research Support, N.I.H., Extramural

Clinical Trial, Phase I

Clinical Trial, Phase III

Comparative Study

Case Reports

Observational Study

Systematic Review

Research Support, U.S. Gov't, P.H.S.

Controlled Clinical Trial

Research Support, N.I.H., Intramural

Evaluation Study

Practice Guideline

Network Meta-Analysis

Equivalence Trial

Publication Year

From

Quick links

Individual year

2024

2023

2022

2021

2020

2018

2017

2016

2015

2014

2013

2012

2011

2010

2009

2008

2007

2006

2005

2004

2003

2002

2001

2000

Sort by:

selected

Print page

Email selected articles

Favourite selected articles

Create a NED Search Alert for this search

Save this search

Advanced Search

Run an advanced search

Results for
""Dacarbazine""[mesh_terms]

112 Results

Searching titles within these results

Congress of Neurological Surgeons systematic review and evidence-based guidelines update on the role of cytotoxic chemotherapy and other cytotoxic therapies in the management of progressive glioblastoma in adults.

Isabelle M Germano, Mateo Ziu, Patrick Wen, D Ryan Ormond, Jeffrey J Olson

Journal of neuro-oncology 2023;158(2):225-253

Full Text

Abstract

Eribulin versus dacarbazine in patients with leiomyosarcoma: subgroup analysis from a phase 3, open-label, randomised study.

Jean-Yves Blay, Patrick Schöffski, Sebastian Bauer, Anders Krarup-Hansen, Charlotte Benson, David R D'Adamo, Yan Jia, Robert G Maki

British journal of cancer 2020;120(11):1026-1032

Free Full Text

Abstract

Phase II clinical study of boron neutron capture therapy combined with X-ray radiotherapy/temozolomide in patients with newly diagnosed glioblastoma multiforme--study design and current status report.

Shinji Kawabata, Shin-Ichi Miyatake, Ryo Hiramatsu, Yuki Hirota, Shiro Miyata, Yoko Takekita, Toshihiko Kuroiwa, Mitsunori Kirihata, Yoshinori Sakurai, Akira Maruhashi, Koji Ono

Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine 2012;69(12):1796-9

Full Text

Abstract

Drug resistance in glioblastoma and cytotoxicity of seaweed compounds, alone and in combination with anticancer drugs: A mini review.

Joana Ferreira, Alice Abreu Ramos, Tânia Almeida, Amaya Azqueta, Eduardo Rocha

Phytomedicine : international journal of phytotherapy and phytopharmacology 2018;48():84-93

Full Text

Abstract

Sorafenib plus dacarbazine in solid tumors: a phase I study with dynamic contrast-enhanced ultrasonography and genomic analysis of sequential tumor biopsy samples.

Vladimir Lazar, Nathalie Lassau, Guillaume Meurice, Yohann Loriot, Carol Peña, Christophe Massard, Caroline Robert, Thomas Robert, Marie-Aude Le Berre, Thierry de Baere, Philippe Dessen, Jean-Charles Soria, Jean-Pierre Armand

Investigational new drugs 2014;32(2):312-22

Full Text

Abstract

Clinical review: Current treatment of malignant pheochromocytoma.

Graeme Eisenhofer, Henning Dralle, Tim Scholz, Karel Pacak, Hendrik Lehnert

The Journal of clinical endocrinology and metabolism 2007;92(4):1217-25

Full Text

Abstract

Potential biochemical therapy of glioma cancer.

Li-Tian Yin, Yue-Jun Fu, Qiao-Ling Xu, Jun Yang, Zeng-Li Liu, Ai-Hua Liang, Xiao-Jun Fan, Cheng-Gang Xu

Biochemical and biophysical research communications 2007;362(2):225-9

Full Text

Abstract

Results of phase I study of a multi-modality treatment for newly diagnosed glioblastoma multiforme using local implantation of concurrent BCNU wafers and permanent I-125 seeds followed by fractionated radiation and temozolomide chemotherapy.

Christopher M McPherson, Margie Gerena-Lewis, John C Breneman, Ronald E Warnick

Journal of neuro-oncology 2012;108(3):521-5

Full Text

Abstract

A conceptually new treatment approach for relapsed glioblastoma: coordinated undermining of survival paths with nine repurposed drugs (CUSP9) by the International Initiative for Accelerated Improvement of Glioblastoma Care.

Richard E Kast, John A Boockvar, Ansgar Brüning, Francesco Cappello, Wen-Wei Chang, Boris Cvek, Q Ping Dou, Alfonso Duenas-Gonzalez, Thomas Efferth, Daniele Focosi, Seyed H Ghaffari, Georg Karpel-Massler, Kirsi Ketola, Alireza Khoshnevisan, Daniel Keizman, Nicolas Magné, Christine Marosi, Kerrie McDonald, Miguel Muñoz, Nathan Sassoon, Mohammad H Pourgholami, Iacopo Sardi, Avishay Sella, Kalkunte S Srivenugopal, Marco Tuccori, Weiguang Wang, Christian R Wirtz, Marc-Eric Halatsch

Oncotarget 2013;4(4):502-30

Free Full Text

Abstract

Sorafenib and dacarbazine in soft tissue sarcoma: a single institution experience.

Bruno Vincenzi, Marianna Silletta, Gaia Schiavon, Anna Maria Frezza, Raimondo Del Vescovo, Bruno Beomonte Zobel, Daniele Santini, Angelo Paolo Dei Tos, Giuseppe Tonini

Expert opinion on investigational drugs 2013;22(1):1-7

Full Text

Abstract

Pharmacokinetic results of a phase I trial of sorafenib in combination with dacarbazine in patients with advanced solid tumors.

Matthias Ludwig, Caroline Robert, Jean-Charles Soria, Jean-Pierre Armand, Chetan Lathia, Stanislas Ropert, Erich Brendel

Cancer chemotherapy and pharmacology 2011;68(1):53-61

Free Full Text

Abstract

Multicenter phase II trial of temozolomide in patients with glioblastoma multiforme at first relapse.

M Brada, K Hoang-Xuan, R Rampling, P Y Dietrich, L Y Dirix, D Macdonald, J J Heimans, B A Zonnenberg, J M Bravo-Marques, R Henriksson, R Stupp, N Yue, J Bruner, M Dugan, S Rao, S Zaknoen

Annals of oncology : official journal of the European Society for Medical Oncology 2001;12(2):259-66

Free Full Text

Abstract

Monitoring temozolomide treatment of low-grade glioma with proton magnetic resonance spectroscopy.

P S Murphy, L Viviers, C Abson, I J Rowland, M Brada, M O Leach, A S K Dzik-Jurasz

British journal of cancer 2004;90(4):781-6

Free Full Text

Abstract

Follow-up of the GHSG HD16 trial of PET-guided treatment in early-stage favorable Hodgkin lymphoma.

Michael Fuchs, Anne Sophie Jacob, Helen Kaul, Carsten Kobe, Georg Kuhnert, Thomas Pabst, Richard Greil, Paul J Bröckelmann, Max S Topp, Marianne Just, Bernd Hertenstein, Martin Soekler, Martin Vogelhuber, Josée M Zijlstra, Ulrich Bernd Keller, Stefan W Krause, Ulrich Dührsen, Julia Meissner, Andreas Viardot, Hans-Theodor Eich, Christian Baues, Volker Diehl, Andreas Rosenwald, Ina Buehnen, Bastian von Tresckow, Markus Dietlein, Peter Borchmann, Andreas Engert, Dennis A Eichenauer

Leukemia 2024;38(1):160-167

Free Full Text

Abstract

Pharmacotherapy for liposarcoma: current and emerging synthetic treatments.

Florence Chamberlain, Charlotte Benson, Khin Thway, Paul Huang, Robin L Jones, Spyridon Gennatas

Future oncology (London, England) 2021;17(20):2659-2670

Free Full Text

Abstract

Results: 1 – 15 / 112

Filters

Expert Opinion

Text Availability

Publication Types

Publication Year

Results for ""Dacarbazine""[mesh_terms]

Congress of Neurological Surgeons systematic review and evidence-based guidelines update on the role of cytotoxic chemotherapy and other cytotoxic therapies in the management of progressive glioblastoma in adults.

Eribulin versus dacarbazine in patients with leiomyosarcoma: subgroup analysis from a phase 3, open-label, randomised study.

Phase II clinical study of boron neutron capture therapy combined with X-ray radiotherapy/temozolomide in patients with newly diagnosed glioblastoma multiforme--study design and current status report.

Drug resistance in glioblastoma and cytotoxicity of seaweed compounds, alone and in combination with anticancer drugs: A mini review.

Sorafenib plus dacarbazine in solid tumors: a phase I study with dynamic contrast-enhanced ultrasonography and genomic analysis of sequential tumor biopsy samples.

Clinical review: Current treatment of malignant pheochromocytoma.

Potential biochemical therapy of glioma cancer.

Results of phase I study of a multi-modality treatment for newly diagnosed glioblastoma multiforme using local implantation of concurrent BCNU wafers and permanent I-125 seeds followed by fractionated radiation and temozolomide chemotherapy.

A conceptually new treatment approach for relapsed glioblastoma: coordinated undermining of survival paths with nine repurposed drugs (CUSP9) by the International Initiative for Accelerated Improvement of Glioblastoma Care.

Sorafenib and dacarbazine in soft tissue sarcoma: a single institution experience.

Pharmacokinetic results of a phase I trial of sorafenib in combination with dacarbazine in patients with advanced solid tumors.

Multicenter phase II trial of temozolomide in patients with glioblastoma multiforme at first relapse.

Monitoring temozolomide treatment of low-grade glioma with proton magnetic resonance spectroscopy.

Follow-up of the GHSG HD16 trial of PET-guided treatment in early-stage favorable Hodgkin lymphoma.

Pharmacotherapy for liposarcoma: current and emerging synthetic treatments.

Results for
""Dacarbazine""[mesh_terms]